Hims & Hers Health, Inc. (NYSE: HIMS) experienced a significant increase in its stock price on August 5,… This article Hims & Hers Health hits 1.9M subscribers! 43% growth year-over-year! 🏆 appeared first on Guerilla Stock Trading. Source link
Pasithea Therapeutics (KTTA) experienced a significant increase in its stock price on August 5, 2024. This surge was… This article Pasithea Therapeutics’ latest update is a game-changer! 📢 Enrollment complete, stock price up! 🔥 appeared first on Guerilla Stock Trading. Source link
Since June 17, 2024, Sanofi-Aventis’s stock has been on an upward trend due to several key factors. The… This article Dupixent approval for COPD in the EU is a game-changer! 🌍 Sanofi is making big moves in the pharma world-Are you in? appeared first on Guerilla Stock Trading. Source link
On July 30, 2024, Imunon (IMNN) stock surged by 258.5% following the release of positive results from the… This article 🔬 A game-changer in cancer treatment! Imunon’s latest trial results show an 11.1-month increase in survival 📊 appeared first on Guerilla Stock Trading. Source link
Get Email Alerts and Follow Us: On May 18, 2024, Mirum Pharmaceuticals revealed important findings at the 56th ESPGHAN Annual Meeting in Milan, showcasing the efficacy of LIVMARLI® (maralixibat) in treating Alagille syndrome (ALGS) and Progressive Familial Intrahepatic Cholestasis (PFIC). Clinical and real-world data indicate significant improvements in patients’ liver health and reduction in pruritus…